The ADRC Human Genetics Core (HGC) was formed in a prior application to provide a centralized resource for the organization and analysis of genetic data for the entire ADRC, and to provide laboratory support for ADRC projects. The overall goal has been to facilitate the understanding of the associations between genetic variants and Alzheimer s disease or related neurodegenerative dementias, and to provide relevant information to investigators and patients and families. The HGC consists of components already well integrated into the Columbia ADRC. 1) A biorepository which includes data management to track biological sample inventories in coordination with the main ADRC database management core; 2) A statistical genetics and genetic epidemiology group to facilitate research involving genetic variables; 3) A board certified genetic counselor with expertise in neurodegenerative disorders available to help clinicians and affected families. Over the past funding cycle the HGC has created and maintained blood specimens (serum, plasma, DNA and immortalized cell lines (when requested) and cerebrospinal fluid) from all willing participants in the ADRC clinical core, Project 3 and all ADRC related studies. In the previous cycle we provided a source of DNA for planned genetic research in Project 3, and for the UDS and ADC collaborative projects, and the Alzheimer s Disease Genetic Consortium which was created to facilitate genetic research across all of the Alzheimer s Disease Centers. Dr. Mayeux, the HGC leader, is a senior co-investigator and member of the steering committee. He has played a major role in the design, and now the analyses, of the Alzheimer s Disease Sequencing Project, another project involving nearly all of the ADCs, epidemiological projects and other cohorts with well characterized cases and controls. The HGC prepared 353 samples from 68 families for the whole-genome sequencing experiment and over 4,000 samples for APOE genotyping. The investigators in this core also played major roles in the design of the Alzheimer s Disease Sequencing Project: Dr. Mayeux is leading the analysis of the family-based whole genome sequencing project of the Alzheimer s Disease Sequencing Project, Dr. Reitz, Co-Project Leader for Project 2 in this application, was involved in the design and will be involved in the analyses of the case-control whole exome project. Dr. Vardarajan, a co-investigator in this core was involved in the planning of the bioinformatics analyses for the family-based whole genome and the case-control whole exome studies as well as the structural variant analyses. The HGC has also been a resource for training of high school and college students in laboratory procedures such as sample preparation, extraction of DNA, banking of serum, plasma and cerebrospinal fluid.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG008702-27
Application #
9088238
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2016-08-01
Project End
2020-05-31
Budget Start
2016-06-01
Budget End
2017-05-31
Support Year
27
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Bravo, Francisca Vaz; Da Silva, Jorge; Chan, Robin Barry et al. (2018) Phospholipase D functional ablation has a protective effect in an Alzheimer's disease Caenorhabditis elegans model. Sci Rep 8:3540
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Grivel, Margaux M; Leong, Wei; Masucci, Michael D et al. (2018) Impact of lifetime traumatic experiences on suicidality and likelihood of conversion in a cohort of individuals at clinical high-risk for psychosis. Schizophr Res 195:549-553
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Zhou, Zilu; Wang, Weixin; Wang, Li-San et al. (2018) Integrative DNA copy number detection and genotyping from sequencing and array-based platforms. Bioinformatics 34:2349-2355
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487

Showing the most recent 10 out of 640 publications